Dr. Carmen Guerra presents on the persistent racial and ethnic disparities that exist in patient access to clinical trials in head and neck oncology.

It is imperative that our HNSCC medical care team across specialties professional remain current in the state-of-the-art techniques (Knowledge).

This session reviews head and neck cancers from a patient perspective.

This session will review the key takeaways from the 2023 Multidisciplinary Thoracic Cancers Symposium.

Prognosis, therapeutic choices, end of life care are three key themes for patients with lung cancer.

Advancements in the diagnosis and treatment of thoracic cancers have improved survival rates, making survivorship issues such as fertility and sexual wellness a priority.

The management of stage III NSCLC is controversial and rapidly evolving, to the point that practitioners have difficulty processing and understanding the fast moving changes in the standard of care and communications among multidisciplinary teams is challenging given the uneven knowledge levels.

The role of multidisciplinary care for small cell lung cancer has never been more important. Novel insights into subclassification of small cell lung cancer may unlock novel therapies that may be effective for each subtype.

Thymic malignancies and mesothelioma are rare cancers that require complex multidisciplinary management.